BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23053160)

  • 1. Erectile dysfunction after prostate three-dimensional conformal radiation therapy. Correlation with the dose to the penile bulb.
    Magli A; Giangreco M; Crespi M; Negri A; Ceschia T; De Giorgi G; Titone F; Parisi G; Fongione S
    Strahlenther Onkol; 2012 Nov; 188(11):997-1002. PubMed ID: 23053160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
    Mangar SA; Sydes MR; Tucker HL; Coffey J; Sohaib SA; Gianolini S; Webb S; Khoo VS; ; Dearnaley DP
    Radiother Oncol; 2006 Sep; 80(3):355-62. PubMed ID: 16949694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
    Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
    Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer.
    Fisch BM; Pickett B; Weinberg V; Roach M
    Urology; 2001 May; 57(5):955-9. PubMed ID: 11337302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with
    Chasseray M; Dissaux G; Bourbonne V; Boussion N; Goasduff G; Malloreau J; Malhaire JP; Fournier G; Tissot V; Pradier O; Valeri A; Schick U
    Acta Oncol; 2019 Jul; 58(7):1029-1035. PubMed ID: 30761939
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results.
    Wilder RB; Chou RH; Ryu JK; Stern RL; Wong MS; Ji M; Roach M; White RD
    Am J Clin Oncol; 2000 Aug; 23(4):330-3. PubMed ID: 10955856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.
    McDonald AM; Baker CB; Shekar K; Popple RA; Clark GM; Yang ES; Jacob R; Kim RY; Fiveash JB
    Urology; 2014 Dec; 84(6):1383-7. PubMed ID: 25440987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation Dose to the Penile Structures and Patient-Reported Sexual Dysfunction in Long-Term Prostate Cancer Survivors.
    Thor M; Olsson CE; Oh JH; Alsadius D; Pettersson N; Deasy JO; Steineck G
    J Sex Med; 2015 Dec; 12(12):2388-97. PubMed ID: 26564611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary patient-reported outcomes analysis of 3-dimensional radiation therapy versus intensity-modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group (RTOG) 0126 prostate cancer trial.
    Bruner DW; Hunt D; Michalski JM; Bosch WR; Galvin JM; Amin M; Xiao C; Bahary JP; Patel M; Chafe S; Rodrigues G; Lau H; Duclos M; Baikadi M; Deshmukh S; Sandler HM
    Cancer; 2015 Jul; 121(14):2422-30. PubMed ID: 25847819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
    Roach M; Winter K; Michalski JM; Cox JD; Purdy JA; Bosch W; Lin X; Shipley WS
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1351-6. PubMed ID: 15590164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile function after prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
    van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
    Sethi A; Mohideen N; Leybovich L; Mulhall J
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):970-8. PubMed ID: 12605975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline status and dose to the penile bulb predict impotence 1 year after radiotherapy for prostate cancer.
    Cozzarini C; Rancati T; Badenchini F; Palorini F; Avuzzi B; Degli Esposti C; Girelli G; Improta I; Vavassori V; Valdagni R; Fiorino C
    Strahlenther Onkol; 2016 May; 192(5):297-304. PubMed ID: 27079673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer.
    Kao J; Turian J; Meyers A; Hamilton RJ; Smith B; Vijayakumar S; Jani AB
    Br J Radiol; 2004 Feb; 77(914):129-36. PubMed ID: 15010385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS; Wallner K; Butler WM; Galbreath RW; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):597-604. PubMed ID: 11395225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.